The aim of the present study is to investigate the effects of the transdermal patch on the endometrium in healthy women who require contraception.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
92
7-day patch containing 0.55 mg ethinylestradiol (EE) and 2.1 mg gestodene (GSD) in a 21-day regimen
Unnamed facility
Berlin, State of Berlin, Germany
Effect on the endometrium at cycle 13
Time frame: 13 treatment cycles (each consisting of 28 days)
Cervical smear
Time frame: 13 treatment cycles (each consisting of 28 days)
Adverse events
Time frame: 13 treatment cycles (each consisting of 28 days)
Cycle control
Time frame: 13 treatment cycles (each consisting of 28 days)
Safety laboratory
Time frame: 13 treatment cycles (each consisting of 28 days)
Occurence of pregnancy
Time frame: 13 treatment cycles (each consisting of 28 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.